← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
St. Louis College Of Pharmacy
St. Louis, MO
$15,044,144
Total funding
19
Grants
Funding over time
peak $3.7M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,044,144 · 19
By mechanism
R01$4,103,458 · 4
R33$3,169,673 · 2
R21$2,031,291 · 5
RF1$1,695,972 · 1
R61$1,195,645 · 2
R34$1,033,359 · 1
Investigators at St. Louis College Of Pharmacy
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Targeting REV-ERB to treat Alzheimer's disease$1,695,972
RF1 · FY2019 · AG
Synthesis of peripherally active CB1 agonists as analgesics$1,033,359
R34 · FY2021 · NS
SMART Polymer Fibers For Tampon-Like Nonsteroidal Contraceptive Devices$804,143
R33 · FY2022 · HD
SMART Polymer Fibers For Tampon-Like Nonsteroidal Contraceptive Devices$754,905
R33 · FY2021 · HD
SMART Polymer Fibers For Tampon-Like Nonsteroidal Contraceptive Devices$709,352
R33 · FY2023 · HD
Developing Chemical Probes for Inflammatory Pain$636,751
R01 · FY2022 · NS
ERRgamma Agonists to Treat Muscular Dystrophy$536,587
R01 · FY2018 · AR
Development of RORalpha and RORgamma Ligands for Treatment of Behavioral Disorders$536,393
R01 · FY2018 · MH
Development of RORalpha and RORgamma Ligands for Treatment of Behavioral Disorders$502,895
R01 · FY2020 · MH
Multipurpose Device for Female-initiated Nonsteroidal On-Demand Contraception$474,946
R61 · FY2025 · HD
Development of RORalpha and RORgamma Ligands for Treatment of Behavioral Disorders$470,731
R01 · FY2019 · MH
Iron Metabolism in Ts65Dn mice, a Model of Down syndrome$465,330
R15 · FY2022 · AG
Peripheral Mechanisms of Kappa Opioid Receptor-Mediated Cold Hypersensitivity$441,584
R01 · FY2022 · NS
Peripheral Mechanisms of Kappa Opioid Receptor-Mediated Cold Hypersensitivity$427,807
R01 · FY2023 · NS
Development of Novel ERRa Selective Agonists as Chemical Probes for the Potential Treatment of Alzheimer's Disease$426,553
R21 · FY2020 · AG
Development of RORalpha and RORgamma Ligands for Treatment of Behavioral Disorders$402,527
R01 · FY2019 · MH
Pharmacological Probes based on mitragynine pseudoindoxyl$396,993
R33 · FY2020 · DA
Pharmacological Probes based on mitragynine pseudoindoxyl$395,106
R33 · FY2021 · DA
SMART Polymer Fibers For Tampon-Like Nonsteroidal Contraceptive Devices$379,800
R61 · FY2019 · HD
The Role of Inositol Polyphosphate 4 Phosphatase in Platelet Functions$355,000
R15 · FY2014 · HL